A groundbreaking study by researchers at Charité University Hospital in Berlin has revealed that synchronizing chemotherapy with the body’s natural circadian rhythms could significantly improve the effectiveness of cancer treatment. The study, which focused on aggressive triple-negative breast cancer, found that chemotherapy drug effectiveness could vary by up to 30% depending on the time of day the drugs are administered.
The research team, led by computational biologist Adrián Enrique Granada, discovered that cancer cells, like all cells in the body, follow a 24-hour cycle known as the circadian rhythm. These internal clocks regulate various cellular functions, including metabolism, DNA repair, and cell division. The study showed that timing chemotherapy to align with these cycles could enhance the efficacy of the treatment.
“Personalized treatment plans based on individual circadian rhythms could substantially improve cancer treatment outcomes,” said Granada, who works at the Charité Comprehensive Cancer Center (CCCC).
New Chronotherapy Approach
To explore the potential of chronotherapy, the team developed a new method called the “chronotherapeutic index.” This technique models and monitors living cells’ circadian rhythms, growth, and drug responses, identifying the optimal times to administer chemotherapy.
In one experiment, the researchers tested chemotherapy drugs on different cell lines, including those from triple-negative breast cancer. The findings were striking: in one specific cell line, chemotherapy was most effective when administered 10 to 12 hours into the cell’s circadian cycle, with the drug 5-fluorouracil (5-FU) showing a “clear preference” for administration between 8 and 10 hours. Meanwhile, other drugs like torin and paclitaxel exhibited more variability in their response times, and some cell lines responded well to treatment at any time of day.
These insights provide a crucial step toward developing personalized cancer treatment plans based on the body’s natural rhythms, with the potential to minimize side effects and improve patient outcomes.
Impact of Circadian Rhythms on Cancer
Cancer cells, like healthy cells, have internal clocks that can affect their growth and response to treatment. Studies have shown that certain types of cancer cells, such as breast cancer, divide and spread at higher rates during the night. Researchers believe this is due to the influence of circadian rhythms on cell activity.
In the past, cancer treatment has generally been administered without considering these natural cycles. However, the Charité team’s study suggests that adjusting treatment times could maximize the effectiveness of chemotherapy. By timing the drugs to coincide with periods of increased cell vulnerability, the treatment could become more potent while reducing unnecessary damage to healthy cells.
Future of Cancer Treatment
While the study’s findings are based on laboratory tests with cell lines, the researchers are optimistic that their chronotherapeutic approach could soon be applied in clinical settings. They are planning further studies to better understand the molecular mechanisms behind circadian influences on drug sensitivity and explore the best timing for chemotherapy in actual cancer patients.
“We’re also planning to study the molecular mechanisms behind the circadian influences on medication sensitivity to further optimize treatment times and identify new therapeutic targets,” Granada said.
The researchers hope that their work will ultimately lead to personalized treatment schedules for cancer patients, increasing survival rates and improving quality of life during treatment.
The full study is published in Nature Communications and represents a promising new frontier in the fight against cancer.
Read Now:Indian Army Inaugurates First On-Site 3D-Printed Structure at Jhansi Military Hospital
